These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


255 related items for PubMed ID: 7629580

  • 1. Thallium-201 scintigraphy in pediatric soft-tissue tumors.
    Howman-Giles R, Uren RF, Shaw PJ.
    J Nucl Med; 1995 Aug; 36(8):1372-6. PubMed ID: 7629580
    [Abstract] [Full Text] [Related]

  • 2. Comparison of gallium-67-citrate and thallium-201 scintigraphy in peripheral and intrathoracic lymphoma.
    Waxman AD, Eller D, Ashook G, Ramanna L, Brachman M, Heifetz L, McAndrews P, Bierman H, Taub R, Avedo M, Wall F.
    J Nucl Med; 1996 Jan; 37(1):46-50. PubMed ID: 8544000
    [Abstract] [Full Text] [Related]

  • 3. Will thallium-201 replace gallium-67 in salivary gland scintigraphy?
    Arbab AS, Koizumi K, Hiraike S, Toyama K, Arai T, Araki T.
    J Nucl Med; 1996 Nov; 37(11):1819-23. PubMed ID: 8917182
    [Abstract] [Full Text] [Related]

  • 4. Scintigraphic evaluation of childhood malignancies by 67Ga-citrate.
    Bekerman C, Port RB, Pang E, Moohr JW, Kranzler JK.
    Radiology; 1978 Jun; 127(3):719-25. PubMed ID: 663163
    [Abstract] [Full Text] [Related]

  • 5. Thymic localization of gallium-67 in pediatric patients with lymphoid and nonlymphoid tumors.
    Hibi S, Todo S, Imashuku S.
    J Nucl Med; 1987 Mar; 28(3):293-7. PubMed ID: 3102700
    [Abstract] [Full Text] [Related]

  • 6. Thallium-201 scintigraphy of neuroblastoma: different results for primary tumors and skeletal lesions.
    Okuyama C, Ushuima Y, Nakamura T, Kikkawa M, Nishimura T.
    Ann Nucl Med; 2001 Apr; 15(2):171-7. PubMed ID: 11448079
    [Abstract] [Full Text] [Related]

  • 7. Nuclear medicine imaging in pediatric oncology.
    Troncone L, Rufini V, Turba R, Mastrangelo R, Riccardi R, Donfrancesco F.
    J Nucl Biol Med (1991); 1994 Mar; 38(1):76-84. PubMed ID: 8075180
    [Abstract] [Full Text] [Related]

  • 8. Clinical significance of thallium-201 scintigraphy in bone and soft tissue tumors.
    Goto Y, Ihara K, Kawauchi S, Ohi R, Sasaki K, Kawai S.
    J Orthop Sci; 2002 Mar; 7(3):304-12. PubMed ID: 12077654
    [Abstract] [Full Text] [Related]

  • 9. Thallium-201 for oncological imaging in children.
    Nadel HR.
    Semin Nucl Med; 1993 Jul; 23(3):243-54. PubMed ID: 8378797
    [Abstract] [Full Text] [Related]

  • 10. Thallium-201 scintigraphy in bone and soft-tissue tumors: a comparison of dynamic, early and delayed scans.
    Sugawara Y, Kikuchi T, Kajihara M, Semba T, Ochi T, Fujii T, Mochizuki T, Sakayama K, Nakata S.
    Ann Nucl Med; 2005 Sep; 19(6):461-8. PubMed ID: 16248382
    [Abstract] [Full Text] [Related]

  • 11. The value of gallium-67 and thallium-201 whole-body and single-photon emission tomography images in dialysis-related beta 2-microglobulin amyloid.
    Yen TC, Tzen KY, Chen KS, Tsai CJ.
    Eur J Nucl Med; 2000 Jan; 27(1):56-61. PubMed ID: 10654148
    [Abstract] [Full Text] [Related]

  • 12. Thallium-201 scintigraphy to predict therapeutic outcome of iodine-131 therapy of metastatic thyroid carcinoma.
    Nakada K, Katoh C, Kanegae K, Tsukamoto E, Shiga T, Mochizuki T, Itoh K, Tamaki N.
    J Nucl Med; 1998 May; 39(5):807-10. PubMed ID: 9591580
    [Abstract] [Full Text] [Related]

  • 13. 131I-meta-iodobenzylguanidine scintigraphy in patients with neuroblastoma.
    Hibi S, Todo S, Imashuku S, Miyazaki T.
    Pediatr Radiol; 1987 May; 17(4):308-13. PubMed ID: 3601463
    [Abstract] [Full Text] [Related]

  • 14. [Sensitivity and specificity of meta-iodobenzylguanidine (mIBG) scintigraphy in the evaluation of neuroblastoma: analysis of 115 cases].
    Lumbroso J, Guermazi F, Hartmann O, Coornaert S, Rabarison Y, Lemerle J, Parmentier C.
    Bull Cancer; 1988 May; 75(1):97-106. PubMed ID: 3359060
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Bone lymphoma: 67Ga scintigraphy and CT for prediction of outcome after treatment.
    Israel O, Mekel M, Bar-Shalom R, Epelbaum R, Hermony N, Haim N, Dann EJ, Frenkel A, Ben-Arush M, Gaitini D.
    J Nucl Med; 2002 Oct; 43(10):1295-303. PubMed ID: 12368366
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Thallium-201 scintigraphy for assessment of a gallium-67-avid mediastinal mass following therapy for Hodgkin's disease.
    Harris EW, Rakow JI, Weiner M, Agress H.
    J Nucl Med; 1993 Aug; 34(8):1326-30. PubMed ID: 8326393
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.